Skip to main content

Table 2 Treatment-related adverse events possibly or probably related to INTUVAX after first and second vaccination

From: Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Reported Adverse event No of related AEs (no. of patients) CTCAE-grade (range)
Fever 8 (5) 1–2
Chills 2 (2) 1
Rash 1 (1) 1
Hypotension 1 (1) 2